Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2011 Financial Results

CORAL GABLES, Fla., April 2, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company that focuses on the development and commercialization of...
March 06, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at 24th Annual ROTH Conference

CORAL GABLES, Fla., March 6, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Chief Executive Officer, will be presenting at the...
February 28, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at Cowen and Company's 32nd Annual Health Care Conference

CORAL GABLES, Fla., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Chief Executive Officer, will be presenting at Cowen...
February 13, 2012 09:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Granted Orphan Medicinal Product Designation in European Union for CPP-115 for the Treatment of West Syndrome (Infantile Spasms)

CORAL GABLES, Fla., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that the European Commission (EC) has granted orphan medicinal product...
February 09, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Files U.S. Provisional Patent Application for GABA Aminotransferase Inhibitor Use in Treatment of Tourette Syndrome

CORAL GABLES, Fla., Feb. 9, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has filed a provisional patent application with the United States...
January 31, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present CPP-115 Progress at the 2012 Epilepsy Pipeline Update Conference

CORAL GABLES, Fla., Jan. 31, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Steven R. Miller, Ph.D., Catalyst's Chief Operating Officer and Chief...
December 20, 2011 10:13 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Announces FDA Designation of CPP-115 as a Fast Track Development Program

CORAL GABLES, Fla., Dec. 20, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that its investigational drug, CPP-115, a novel GABA aminotransferase...
December 15, 2011 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Scientific Paper Regarding CPP-115 for the Treatment of Cocaine Addiction Accepted for Publication in the Journal of Medicinal Chemistry

CORAL GABLES, Fla., Dec. 15, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) (Company) today announced that a scientific paper on CPP-115 describing preclinical data...
December 13, 2011 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Phase I(a) Safety Study for CPP-115

CORAL GABLES, Fla., Dec. 13, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that it has commenced its first in man Phase I(a) safety study for its...
December 02, 2011 10:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Presentation to be Made at the American Epilepsy Society's 65th Annual Meeting

CORAL GABLES, Fla., Dec. 2, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced that a poster presentation demonstrating that CPP-115, Catalyst's...